As imaging volume continues to grow along with the demand for faster turnaround times and earlier detection, the technology and tools that improve efficiency and accuracy are essential. Our ClearRead™ Chest cardiothoracic AI suite of products has been designed specifically for that purpose.
Our ClearRead™ Chest imaging interpretation solutions are built upon advanced AI algorithms that target the biggest health threats globally. A full suite of ClearRead Chest solutions are purpose-built to detect disease earlier, more efficiently, and provide improved patient outcomes. These AI tools target the most prevalent global chest conditions including lung cancer and cardiovascular disease.
Lung cancer
Pneumothorax
Coronary Artery Calcification (CAC)
ClearRead Chest is the only solution with unique and patented suppression technology for thoracic imaging interpretation that removes the interfering normal structures within the chest for an unimpaired view that improves detection accuracy and decreases reading time.
The ClearRead Chest suite of products utilizes a series of advanced AI algorithms that are deployed on chest CTs and X-rays. Our unique and patented bone and vessel suppression technology removes interfering structures for an unimpaired view of the chest. Our FDA-cleared software allows radiologists to better focus on critical findings.
A common obstacle in developing reliable medical AI is the scarcity of high-quality training datasets with complex and challenging abnormalities. Riverain tackles this problem by using both robust and diverse data sets along with synthetic data. This process allows Riverain to train its algorithms on massive, diverse datasets that include many more atypical cases than would be possible with only real-world data.
Deep learning, a form of machine learning, is particularly effective at recognizing patterns in complex images and provides the core computational engine for our ClearRead suite. Unlike other AI-driven medical technologies that often crumble under scrutiny, Riverain’s ClearRead technology has undergone extensive testing, proving its reliability even in atypical cases.
The quality and appearance of CT scans can vary considerably, which can make consistent and accurate interpretation challenging. ClearRead processes images or scans in such a way that they appear as if they came from a single device. Removing inter-device, or acquisition protocol, variation is essential to producing robust and consistent results from automated analysis.
Riverain’s unique technological solutions address challenges that radiologists and medical groups regularly encounter.
Achieving high reliability and significant performance doesn’t equate to slow processing times. ClearRead images process quickly within minutes and are waiting at the patient series for review. CPU and GPU processing is available to meet your unique needs.
ClearRead handles a broad range of acquisition protocols. Conventional approaches typically collect data from different sensors to adjust component algorithms. This leaves them vulnerable to changes in hardware, protocols, and reconstruction methods. Riverain’s adaptive process allows our software to be vendor-neutral.
Our exclusive vessel suppression technology not only enables better nodule definition, but also allows for highly precise segmentation of these nodules, providing an accurate assessment of size, volume, and other general nodule characteristics.
ClearRead output is available on the existing PACS review stations, eliminating the need for costly dedicated workstations and disjointed workflows. See how it will work within your workflow.
Learn More
